Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Homaira, Hanif"'
Autor:
Morgan S. Brown, Homaira Hanif, Kristen M. Little, Meredith R. Clark, Andrea R. Thurman, Lola Flomen, Gustavo F. Doncel
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background While oral pre-exposure prophylaxis (PrEP) has been shown to reduce the risk of HIV, challenges such as adhering to a daily-dosing regimen and persistence have emerged as barriers for at-risks populations in South Africa. This qua
Externí odkaz:
https://doaj.org/article/d5e31ac393df4fc6ab1482867d956379
Autor:
Andrea R. Thurman, Louise A. Ouattara, Nazita Yousefieh, Peter L. Anderson, Lane R. Bushman, Xi Fang, Homaira Hanif, Meredith Clark, Onkar Singh, Gustavo F. Doncel
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 13 (2023)
BackgroundNew multi-purpose prevention technology (MPT) products are needed to prevent human immunodeficiency virus (HIV) and herpes simplex virus type 2 (HSV2). In this study, we evaluated a fast-dissolve insert that may be used vaginally or rectall
Externí odkaz:
https://doaj.org/article/a9cd0edaab2c403583152c032fe80051
Publikováno v:
Frontiers in Reproductive Health, Vol 5 (2023)
IntroductionMost women face multiple and co-occurring risks from unwanted pregnancy, human immunodeficiency virus (HIV) and other sexually transmitted infections (STIs) at some point during their lifetime. While a range of contraceptive methods exist
Externí odkaz:
https://doaj.org/article/1730ef7119b545829a88ddeccff39731
Autor:
Andrea R. Thurman, Vivian Brache, Leila Cochon, Louise A. Ouattara, Neelima Chandra, Terry Jacot, Nazita Yousefieh, Meredith R. Clark, Melissa Peet, Homaira Hanif, Jill L. Schwartz, Susan Ju, Mark A. Marzinke, David W. Erikson, Urvi Parikh, Betsy C. Herold, Raina N. Fichorova, Elizabeth Tolley, Gustavo F. Doncel
Publikováno v:
PLoS ONE, Vol 17, Iss 10 (2022)
Multipurpose prevention technologies (MPTs), which prevent sexually transmitted infection(s) and unintended pregnancy, are highly desirable to women. In this randomized, placebo-controlled, phase I study, women used a placebo or tenofovir (TFV) and l
Externí odkaz:
https://doaj.org/article/acce84a034c84494b2798735f3302ad2
Autor:
Seth Zissette, Elizabeth E Tolley, Andres Martinez, Homaira Hanif, Katherine Gill, Nelly Mugo, Laura Myers, Ednar Casmir, Menna Duyver, Kenneth Ngure, Gustavo F Doncel
Publikováno v:
PLoS ONE, Vol 16, Iss 5, p e0251823 (2021)
IntroductionOral, vaginal and other pre-exposure prophylaxis (PrEP) products for HIV prevention are in various stages of development. Low adherence poses a serious challenge to successful evaluation in trials. In a previous study, we developed tools
Externí odkaz:
https://doaj.org/article/b2d902d873f147d580fad67ae332ba2f
Autor:
Elizabeth E. Tolley, Seth Zissette, Jamilah Taylor, Homaira Hanif, Susan Ju, Jill Schwarz, Andrea Thurman, Danielle Tyner, Vivian Brache, Gustavo F. Doncel
Publikováno v:
Journal of women's health (2002). 31(9)
Autor:
M. Melissa Peet, Vivek Agrahari, Sharon M. Anderson, Homaira Hanif, Onkar N. Singh, Andrea R. Thurman, Gustavo F. Doncel, Meredith R. Clark
Publikováno v:
Pharmaceutics, Vol 11, Iss 8, p 374 (2019)
The development of topical inserts for the prevention of sexually transmitted infections (STIs), particularly human immunodeficiency virus (HIV), represents a promising alternative to oral and parenteral pre-exposure prophylaxis (PrEP) dosage forms.
Externí odkaz:
https://doaj.org/article/66febb17828a4117a135be7ce3c80bba
Autor:
Kristen M. Little, Lola Flomen, Homaira Hanif, Sharon M. Anderson, Andrea R. Thurman, Meredith R. Clark, Gustavo F. Doncel
Publikováno v:
AIDS and behavior. 26(9)
For adolescent girls (AG) and young women (YW), adherence barriers may limit the effectiveness of daily oral HIV pre-exposure prophylaxis (PrEP). Due to its low-burden and long-lasting product attributes, PrEP implants could remove some of the critic
Autor:
Morgan S, Brown, Homaira, Hanif, Kristen M, Little, Meredith R, Clark, Andrea R, Thurman, Lola, Flomen, Gustavo F, Doncel
Background While oral pre-exposure prophylaxis (PrEP) has been shown to reduce the risk of HIV, challenges such as adhering to a daily-dosing regimen and persistence have emerged as barriers for at-risks populations in South Africa. This qualitative
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::367859db6d6e660efc6548f8ade2d1ed
https://doi.org/10.21203/rs.3.rs-1335381/v1
https://doi.org/10.21203/rs.3.rs-1335381/v1
Autor:
Elizabeth T. Montgomery, Rachel Weinrib, Prisca Mutero, Mary Kate Shapley-Quinn, Enyonam Odoom, Jenni Smit, Petina Musara, Zvavahera M. Chirenje, Homaira Hanif, Quatro Study Team, Ariane van der Straten, Cecilia Milford, Nyaradzo Mgodi, Meredith R. Clark
Publikováno v:
AIDS and Behavior. 25:124-138
The attributes of an HIV microbicide may affect its acceptability, uptake and use. Quatro, a clinical study with a qualitative component, was conducted to elicit input from end-users and key informants (KIs) on four different placebo vaginal microbic